BPS-03251

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBPS-03251
Drug Alias NameTGF inhibitor (Beijing Pharmasciences)BPS-03251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Pharmstar Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Pharmstar Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A